Current filters:


Popular Filters

1101 to 1125 of 1185 results

Watson 4th-quarter beats expectations, with 93% rise in net income


US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) reported a whopping 62% increase to $1.5 billion…

FinancialGenericsWatson Pharmaceuticals

Rush Bill would make most patent settlement deals in USA unlawful


Last week, US Representative Bobby Rush (Democrat, Illinois) introduced HR 3995, the Protecting Consumer…

GenericsLegalNorth AmericaPharmaceuticalRegulation

Watson confirms patent challenge to Bayer’s Beyaz


US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) on Friday confirmed that its subsidiary, Watson…

BayerBeyazGenericsNorth AmericaPatentsRegulationReproductiveWatson Pharmaceuticals

Fitch backs FDA planned guidelines, saying they open the door to biosimilars


Fitch Ratings believes the US Federal Drug and Administration's proposed biosimilar pathway regulations,…

BiotechnologyGenericsHospiraNorth AmericaRegulation

At last, draft guidance on biosimilars pathway from US FDA


Coming somewhat behind European Union action, the US Food and Drug Administration late yesterday issued…

BiotechnologyGenericsNorth AmericaRegulation

Hospira challenges Cubist patents on Cubicin


US drugmaker Cubist Pharmaceuticals (Nasdaq: CBST) says that it has received a Paragraph IV Notice Letter…

Antibiotics and Infectious diseasesCubicinCubist PharmaceuticalsGenericsHospiraNorth AmericaPatentsPharmaceuticalResearch

Further protests from activists against EU and India FTA


As India and the European Union meet today for a Summit in New Delhi to iron out the differences over…

Asia-PacificEuropeGenericsMarkets & MarketingPatentsPharmaceuticalPolitics

New low cost HIV drug to be made by Ugandan company


Starting as early as next month, Uganda will produce a new low cost and more effective life saving HIV/AIDS…

Anti-viralsGenericsMarkets & MarketingRest of the WorldTenofovir Disoproxil Fumarate

Generics will drive Australia’s PBS saving in 2012, says GMiA


Australian patients and taxpayers need to make the most of the unprecedented value of medicines coming…


Watson settles with Janssen over Ortho Tri-Cyclen LO


US generic drugmaker Watson Pharmaceutical (NYSE: WPI) says that its subsidiary, Watson Laboratories,…

GenericsJanssenJohnson & JohnsonLegalNorth AmericaPatentsReproductiveWatson PharmaceuticalsWomen's Health

Sanofi fourth-quarter in line with forecasts; collects damages


French drug major Sanofi (Euronext: SAN) this morning reported 8.8% growth in fourth-quarter 2011 sales…

ApotexBristol-Myers SquibbFinancialGenericsLegalPatentsPharmaceuticalPlavix

Zydus Cadila third-quarter revenues up 20%


Indian drugmaker Zydus Cadila posted total revenue of 14.01 billion rupees ($287.7 million) for the third…

FinancialGenericsZydus Cadila

Shanghai Pharma aims to take control of Kony Pharma


In a regulatory filing with the Hong Kong Stock Exchange yesterday, Shanghai Pharmaceuticals Holding…

Asia-PacificGenericsKony PharmaMergers & AcquisitionsShanghai Pharmaceutical Group

New bipartisan legislation to address US drug shortages


US Representatives John Carney (Democrat, Delaware) and Larry Bucshon (Republican, Indian) last week…

GenericsLegalNorth AmericaPharmaceuticalRegulation

Dr Reddy’s beats forecasts, with 88% profits hike


India drug major Dr Reddy’s Laboratories (500124: BO) saw its shares rise 2.2% to 1,670.50 rupees…

Dr Reddy's LaboratoriesFinancialGenerics

New Actavis/Bioton alliance aims to shake up diabetes market


Icelandic generics drugmaker Actavis and Poland’s Bioton (WSE: BIO) have formed a joint venture…

ActavisBiotonDiabetesGenericsMarkets & MarketingMergers & AcquisitionsPharmaceutical

STADA and Grunenthal agree lower price for certain branded products


German drugmakers STADA Arzneimittel (SAZ: GR) and family-owned Grunenthal have agreed on the purchase…

EuropeGenericsGrunenthalMergers & AcquisitionsSTADA Arzneimittel

EC and Italian government seek to boost generic medicine use


The European Commission’s formal call last week on Italy to comply with European Union rules on…

EuropeGenericsMarkets & MarketingPatentsPharmaceuticalPoliticsRegulation

EC closes procedural case against Servier


The European Commission said last Friday that it has closed an investigation into Fremch independent…

EuropeGenericsMarkets & MarketingPharmaceuticalRegulationServier

Department of Justice seeks permanent injunction against Ranbaxy


The US Department of Justice, on behalf of the Food and Drug Administration, has filed a consent decree…

Asia-PacificGenericsLegalNorth AmericaRanbaxy LaboratoriesRegulation

Kenya court set to deliver ruling on anti-counterfeit law


After almost three years of waiting since three petitioners living with HIV filed a constitutional petition…

GenericsLegalMarkets & MarketingPharmaceuticalRest of the World

1101 to 1125 of 1185 results



Back to top